Breast Neoplasms: all 12,820 studies
Page 117 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.
- Various G-CSF Regimens to Prevent Infection During ChemotherapyCompletedNCT00536081Phase 3
- Testing Digital Breast Tomosynthesis vs. Regular Mammogram in Detecting Breast Cancer in Women Having Screening MammogramCompletedNCT00535678
- Phase II Trial of Neoadjuvant[FEC100]/Cisplatin-Docetaxel ± Trastuzumab in Women With Over Expressed or Amplified Her2/Neu With Locally Advanced Breast CancerCompletedNCT00535509Not applicable
- Optimal Duration of Pre-operative Treatment With Letrozole and to Correlate Clinical Efficacy With Appropriate Surrogate MarkersCompletedNCT00535418Phase 2/3
- Test of Digital Breast Tomosynthesis vs. Regular Mammography in Detecting Breast Cancer in Women Undergoing Diagnostic MammographyCompletedNCT00535327
- Test of Digital Breast Tomosynthesis vs. Common Mammography to Detect Breast Cancer for Women Undergoing Breast BiopsyCompletedNCT00535184
- Neuropathic Pain in Survivors of Breast CancerCompletedNCT00535067
- Prospective & Retrospective Data Collection of Breast Cancer Cases From 2000 to PresentCompletedNCT00534755Early Phase 1
- Positron Emission Tomography Using 3'-Deoxy-3'-(18F) Fluorothymidine in Treating Women With Locally Advanced Cancer in One Breast Who Are Receiving ChemotherapyCompletedNCT00534274Not applicable
- Trastuzumab or Observation After Combination Chemotherapy and Trastuzumab in Treating Patients Undergoing Surgery for Stage II or Stage III Breast CancerStatus unknownNCT00533936Phase 2
- Healing Touch During Chemotherapy Infusions for Women With Breast CancerCompletedNCT00533663Not applicable
- Effect of SBG in Patients With Breast CancerCompletedNCT00533364Phase 1/2
- Weight Gain Prevention for Breast Cancer SurvivorsStatus unknownNCT00533338Not applicable
- Phase II Study of Primary Chemotherapy With Paclitaxel, Gemcitabine, and TrastuzumabCompletedNCT00532857Phase 2
- Triple Negative Breast Cancer TrialStatus unknownNCT00532727Phase 3
- Phase II Study of Irinotecan/Capecitabine in Patients With Antracycline/Taxane Pretreated MBCCompletedNCT00532714Phase 2
- Phase II Study of Gemcitabine/Vinorelbine vs Sequential Gemcitabine Followed by Vinorelbine in Metastatic Breast CancerCompletedNCT00532623Phase 2
- Evaluation of the Association Between CYP2D6 Genetic Polymorphisms and the Treatment Effect of TamoxifenTerminatedNCT00532454Phase 2
- Primary Paclitaxel Plus Gemcitabine in Patients With Stage II and III Breast CancerTerminatedNCT00532285Phase 2
- Goserelin/Letrozole in Premenopausal Patients vs Letrozole Alone in Postmenopausal Patients With MBCCompletedNCT00532272Phase 2
- A Study of Liposomal Doxorubicin in Women With Breast Cancer Exploiting Tissue Doppler ImagingStatus unknownNCT00531973Phase 4
- ABI-008 Trial in Patients With Metastatic Breast CancerTerminatedNCT00531271Phase 1/2
- Views on Sharing Family Medical History in Healthy Women Undergoing Mammograms or Breast EvaluationWithdrawnNCT00530751
- Evaluation of Clinical Significance of Circulating Markers in Breast Cancer Patients Undergoing Herceptin TherapyStatus unknownNCT00530569
- Effect on Clip Markers After Vacuum-Assisted Biopsy by Postprocedure MammogramCompletedNCT00529737Not applicable
- A Pilot Study of CyberKnife Radiosurgery Delivered to the Partial BreastWithdrawnNCT00529334Not applicable
- Phase II Trial of Oxaliplatin in Combination With S-1(SOX) in Patients With Recurrent or Metastatic Breast CancerCompletedNCT00527930Phase 2
- Neoadjuvant Chemotherapy of Primary Breast Cancer With Epirubicin/Docetaxel and Carboplatin/DocetaxelCompletedNCT00527449Phase 2
- Partial Breast Radiation Therapy in Treating Women Undergoing Breast-Conserving Therapy for Early Stage Breast CancerCompletedNCT00527293Early Phase 1
- BI 2536 in Treating Patients With Recurrent or Metastatic Solid TumorsCompletedNCT00526149Phase 2
- Phase I-II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 in Advanced Solid Malignancies, and Efficacy in HER2+ or ER+ Locally Advanced or Metastatic Breast Cancer PatientsCompletedNCT00526045Phase 1/2
- Cancer Genetics CD-ROM for HispanicsCompletedNCT00525980Not applicable
- Investigating the Biological Effects of the Addition of Zoledronic Acid to Pre-operative Chemotherapy in Breast CancerCompletedNCT00525759Phase 2
- Study of Suitable Schedule of Docetaxel,Anthracycline and Cyclophosphamide in Adjuvant Therapy of Beast CancerStatus unknownNCT00525642Phase 2/3
- Exemestane + Celecoxib vs Exemestane + Placebo in Metastatic Breast CancerCompletedNCT00525096Phase 3
- Zometa and Circulating Vascular Endothelial Growth Factor (VEGF) in Breast Cancer Patients With Bone MetastasisCompletedNCT00524849Phase 2/3
- Liposomal Doxorubicin and Docetaxel in Metastatic Breast CancerCompletedNCT00524810Phase 2
- Vaccine Therapy in Treating Patients With Breast CancerCompletedNCT00524277Phase 2
- APOLLO(Aromatase Inhibitor Patient cOmpLiance Program With qoL Questionaire)CompletedNCT00523315
- Alberta Physical Activity and Breast Cancer Prevention (ALPHA) TrialCompletedNCT00522262Not applicable
- Factors Affecting Decisions About Breast Reconstruction After Mastectomy in Black and Latina WomenCompletedNCT00519974
- Prayer as a Possible Adjuvant Treatment for Breast CancerCompletedNCT00519545Not applicable
- Sleep, Circadian Hormonal Dysregulation, and Breast Cancer SurvivalCompletedNCT00519168
- Phase II Study in Patients With Operable Breast CancerStatus unknownNCT00518583Phase 2
- Level of Physical Activities in Patients Before and After Breast Cancer TreatmentCompletedNCT00517088Not applicable
- Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast CancerCompletedNCT00516698
- Dehydroepiandrosterone (DHEA) and Letrozole in Treating Patients With Metastatic Breast CancerTerminatedNCT00516542Phase 1
- Doxorubicin or Epirubicin and Cyclophosphamide in Treating Older Women With Invasive Breast CancerStatus unknownNCT00516425Phase 3
- Defined Green Tea Catechin Extract in Treating Women With Hormone Receptor Negative Stage I-III Breast CancerCompletedNCT00516243Phase 1
- Prevention of Persistent Alopecia Following Docetaxel by Means of Scalp CoolingCompletedNCT00515762Phase 2
- Effect of Dietary Soy on Estrogens in Breast Fluid, Blood, and Urine Samples From Healthy WomenCompletedNCT00513916Phase 3
- Lapatinib and Vinorelbine in Treating Women With HER2-Overexpressing Locally Advanced or Metastatic Breast CancerCompletedNCT00513058Phase 1
- Postoperative Use of Zoledronic Acid in Breast Cancer Patients After Neoadjuvant ChemotherapyCompletedNCT00512993Phase 3
- Study to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cancer TumorsTerminatedNCT00511576Phase 1
- Phase 2 Study of AMG 386 Plus Paclitaxel With or Without Bevacizumab as First Line Therapy in Her2-Negative Breast Cancer PatientsCompletedNCT00511459Phase 2
- Primary Breast Cancer Occurring Concomitant With PregnancyCompletedNCT00510367Early Phase 1
- Physical Activity or Usual Care in Preventing Weight Gain in Women With Stage I or Stage II Breast Cancer Undergoing ChemotherapyCompletedNCT00509626Phase 1/2
- High Risk Breast Cancer Screening ProgramStatus unknownNCT00509509
- Effects of Yoga in Breast Cancer PatientsCompletedNCT00508794Not applicable
- PTC299 and Hormonal Agent for Treatment of Metastatic Breast CancerCompletedNCT00508586Phase 1
- Evaluation of a Novel CT-On-Rails or Trilogy Stereotactic Spine Radiotherapy System (SSRS)Active, not recruitingNCT00508443Phase 1/2
- Tibetan Yoga in Improving Fatigue and Sleep in Participants With Stage I-III Breast CancerCompletedNCT00507923Not applicable
- Safety and Efficacy Study Using Rexin-G for Breast CancerCompletedNCT00505271Phase 1/2
- Safety of Ovarian Stimulation With Letrozole and Gonadotropins in Breast Cancer PatientsTerminatedNCT00504699Not applicable
- 3-Dimensional Form and Soft Tissue Biomechanics of the BreastTerminatedNCT00502814
- Perioperative Administration of COX 2 Inhibitors and Beta Blockers to Women Undergoing Breast Cancer SurgeryStatus unknownNCT00502684Not applicable
- Evaluation of Maxy-G34 in Breast Cancer Patients Treated With TAC (Docetaxel, Adriamycin, Cyclophosphamide) ChemotherapyStatus unknownNCT00501332Phase 2
- Pain Management Following TRAM Flap for Breast ReconstructionCompletedNCT00500565Not applicable
- Breast Cancer Risk Assessment Using Optical Breast Spectroscopy (OBS)CompletedNCT00500383
- Near Infrared/ Ultrasound Dual Modal Imaging for Breast Cancer DiagnosisCompletedNCT00499980
- Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial CancerTerminatedNCT00499733Early Phase 1
- Phase 2b Study of Taxol Plus Sorafenib or Placebo in Patients With Advanced Breast CancerStatus unknownNCT00499525Phase 2
- Partial Breast Irradiation With Interstitial High Dose Rate BrachytherapyStatus unknownNCT00499057Phase 2
- Letrozole and Goserelin or Leuprolide in Treating Premenopausal Estrogen Receptor-Positive Patients With Stage IV Breast CancerTerminatedNCT00498901Phase 2
- Safety and Efficacy Study of GCSF Therapy to Treat Patients at High Risk for Chemotherapy Induced Severe NeutropeniaCompletedNCT00497809Phase 2
- Androgen Therapy for Breast Cancer Patients With Aromatase Inhibitor Induced Side-EffectsStatus unknownNCT00497458Phase 2
- Predictors for Response to Dose-dense Docetaxel and Epirubicin Breast CancerActive, not recruitingNCT00496795Phase 2
- Trial of Patient Navigation-ActivationCompletedNCT00496678Phase 4
- ZD6474 (Zactima) and Metronomic Chemotherapy in Advanced Breast CancerCompletedNCT00496665Phase 1
- Chemotherapy-Induced Changes to Cognition and DNA in Breast Cancer SurvivorsCompletedNCT00496613
- Prophylactic Irradiation to the Contralateral Breast for BRCA Mutation Carriers Undergoing Treatment for Breast CancerStatus unknownNCT00496288Phase 2
- Pre-Surgical Qigong Therapy for Women With Breast CancerCompletedNCT00495209
- Prospective Validation Trial of Circulating Tumor Cells (CTCs) in Women With Metastatic Breast CancerCompletedNCT00493350
- Erlotinib Plus Chemotherapy for Treatment of Triple Negative Breast CancerStatus unknownNCT00491816Phase 2
- Non-Invasive Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy Techniques (MRS) for Assessing Neoadjuvant Chemotherapy in Locally Advanced Breast CancerCompletedNCT00490503
- Strength and Range of Motion in Women Undergoing Surgery for Breast CancerCompletedNCT00489125
- A Prospective, Single-Arm Study to Evaluate the Efficacy and Safety of Zoladex 3.6mg Combined With CEF Chemotherapy as Neo-Adjuvant Therapy in Hormone Responsive, Premenopausal, Operable Breast CancerStatus unknownNCT00488722Not applicable
- A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast CancerStatus unknownNCT00486668Phase 3
- Treatment of Larotaxel/Docetaxel, +/- Trastuzumab, After Anthracycline-cyclophosphamide in Breast Cancer PatientsCompletedNCT00485979Phase 2
- A Safety and Immunology Study of a Modified Vaccinia Vaccine for HER-2(+) Metastatic Breast CancerCompletedNCT00485277Phase 1
- Study the Role of Positron Emission Mammography in Pre-surgical Planning for Breast CancerStatus unknownNCT00484614Phase 4
- Sunitinib in Treating Patients With Newly Diagnosed Stage II or Stage III Breast Cancer That Can Be Removed by SurgeryCompletedNCT00482755Phase 2
- Gemcitabine/Vinorelbine Versus Gemcitabine/Cisplatin Versus Gemcitabine/Capecitabine in Metastatic Breast CancerCompletedNCT00480597Phase 2
- Association of Dihydropyrimidine Dehydrogenase (DPYD) Variants With Toxicity Related to CapecitabineCompletedNCT00478686
- Views and Attitudes of Oncologists and Geriatricians on the Use of Chemotherapy and Hormone Therapy in Treating Older and/or Frail Women With Breast CancerCompletedNCT00478283Not applicable
- A Pilot Study Evaluating the Immunologic Status of Patients With HER2+ Breast CancerCompletedNCT00477139
- Yoga Study in Breast Cancer PatientsCompletedNCT00476203Not applicable
- Safety and Tolerability Study of AZD2171 in Combination With AZD0530 in Patients With Advanced Solid TumoursCompletedNCT00475956Phase 1
- Breast Mammogram and Tissue StudyCompletedNCT00475761
- Breast MRI in Women With Known or Suspected Breast Cancer and in Healthy ParticipantsCompletedNCT00474604Not applicable